ArticleIrish journal of medical science2026
Evaluation of liver function and related factors in patients with chronic hepatitis B-related cirrhosis complicated with esophagogastric variceal bleeding.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study intended to evaluate liver function and related factors in patients with chronic hepatitis B (CHB)-related cirrhosis complicated with esophagogastric variceal bleeding (EGVB).
methodsPatients with CHB-related cirrhosis complicated with EGVB were screened from the multicenter database. Patients were divided into Child-Pugh A, B, and C based on Child-Pugh scores. Clinical characteristics and laboratory findings were collected to explore factors affecting good liver function (Child-Pugh A: good liver function; Child-Pugh B or C: poor liver function).
resultsA total of 356 eligible patients were included after applying predefined inclusion and exclusion criteria from an initial multicenter cohort, including 62 (17.4%) patients with Child-Pugh A, 233 (65.5%) with Child-Pugh B, and 61 (17.1%) with Child-Pugh C. Aspartate transaminase, creatinine, and viral marker status differed significantly among groups. No difference was found in clinical characteristics or laboratory indexes except for Child-Pugh indexes among patients with Child-Pugh A, B, and C. HBsAg (+), HBeAg (+), and Anti-HBc (+) and creatinine were independently and negatively related to good liver function.
conclusionPatients with CHB-related cirrhosis complicated with EGVB show different degrees of liver dysfunction, and they are suggested to be classified into three subtypes A, B, and C according to Child-Pugh classification. HBsAg (+), HBeAg (+), and Anti-HBc (+) is related to poor liver function, and positive antiviral therapy may be beneficial for the prevention of liver function damage in these patients.
Indexed as
Identifiers
42065812What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.